The company
Capricor Therapeutics, Inc.
CAPR · Nasdaq
CAPR stood above a rising 150-day average in 28 of the last 52 weekly readings, and has been out of that trend for the last 17 weeks. It is 66.9% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 17
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $16.7M
- Officials’ trades on record
- 2
- Institutions holding
- 164 (-5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
2 disclosed lines: House 2, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Roger Marshall House: U.S. House ClerkKS01 | bought | $1k–$15k | 27 Jul 2017filed 6 Aug 2018 |
| Roger Marshall House: U.S. House ClerkKS01 | solddependent child | $1k–$15k | 27 Jul 2017filed 6 Aug 2018 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Karen KrasneyEVP, GENERAL COUNSEL | sold | 24,100at $30.38 | 25 Jun 2026filed 29 Jun 2026 |
| Anthony BergmannCHIEF FINANCIAL OFFICER | sold | 24,100at $30.38 | 25 Jun 2026filed 29 Jun 2026 |
| Karen KrasneyEVP, GENERAL COUNSEL | sold | 400at $30.00 | 24 Jun 2026filed 24 Jun 2026 |
| Anthony BergmannCHIEF FINANCIAL OFFICER | sold | 400at $30.00 | 24 Jun 2026filed 24 Jun 2026 |
| Karen KrasneyEVP, GENERAL COUNSEL | sold | 500at $30.00 | 22 Jun 2026filed 24 Jun 2026 |
| Anthony BergmannCHIEF FINANCIAL OFFICER | sold | 500at $30.00 | 22 Jun 2026filed 24 Jun 2026 |
| Karen KrasneyEVP, GENERAL COUNSEL | sold | 25,000at $31.70 | 1 May 2026filed 4 May 2026 |
| Anthony BergmannCHIEF FINANCIAL OFFICER | sold | 25,000at $31.70 | 1 May 2026filed 4 May 2026 |
| Karimah Es SabarDirector | sold | 7,529at $32.00 | 2 Apr 2026filed 3 Apr 2026 |
| Karimah Es SabarDirector | sold | 53,735at $31.03 | 1 Apr 2026filed 1 Apr 2026 |
| Karen KrasneyEVP, GENERAL COUNSEL | sold | 25,000at $30.12 | 31 Mar 2026filed 1 Apr 2026 |
| Anthony BergmannCHIEF FINANCIAL OFFICER | sold | 25,000at $30.13 | 31 Mar 2026filed 1 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,145,061$99.8M | +723,246+21.1% |
| TANG CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 4,099,900$98.7M | +700,000+20.6% |
| MONTANOVA CAPITAL, LLCadded · filed 14 Aug 2026 | 4,092,784$98.6M | +274,184+7.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,397,150$81.8M | +1,215,249+55.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,297,674$55.3M | +269,942+13.3% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 1,578,131$38.0M | +666,155+73.0% |
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 1,507,844$36.3M | 00.0% |
| Boxer Capital Management, LLCadded · filed 14 Aug 2026 | 1,395,156$33.6M | +805,156+136.5% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,372,286$33.0M | +253,960+22.7% |
| FMR LLCadded · filed 13 Aug 2026 | 1,137,730$27.4M | +365,081+47.3% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.